203 related articles for article (PubMed ID: 31174285)
1. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.
Egorova AA; Shtykalova SV; Maretina MA; Sokolov DI; Selkov SA; Baranov VS; Kiselev AV
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31174285
[TBL] [Abstract][Full Text] [Related]
2. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
Egorova AA; Maretina MA; Kiselev AV
Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
[TBL] [Abstract][Full Text] [Related]
3. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
4. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
Kleinman ME; Yamada K; Takeda A; Chandrasekaran V; Nozaki M; Baffi JZ; Albuquerque RJ; Yamasaki S; Itaya M; Pan Y; Appukuttan B; Gibbs D; Yang Z; Karikó K; Ambati BK; Wilgus TA; DiPietro LA; Sakurai E; Zhang K; Smith JR; Taylor EW; Ambati J
Nature; 2008 Apr; 452(7187):591-7. PubMed ID: 18368052
[TBL] [Abstract][Full Text] [Related]
5. Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells.
Egorova A; Pyankov I; Maretina M; Baranov V; Kiselev A
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681181
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model.
Egorova A; Petrosyan M; Maretina M; Balashova N; Polyanskih L; Baranov V; Kiselev A
Gene Ther; 2018 Dec; 25(8):548-555. PubMed ID: 30254304
[TBL] [Abstract][Full Text] [Related]
7. Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis.
Egorova A; Maretina M; Krylova I; Kiselev A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203184
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.
Zhang L; Lv Z; Xu J; Chen C; Ge Q; Li P; Wei D; Wu Z; Sun X
FEBS J; 2018 Apr; 285(7):1359-1371. PubMed ID: 29474747
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
10. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.
Egorova A; Selutin A; Maretina M; Selkov S; Baranov V; Kiselev A
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33050526
[TBL] [Abstract][Full Text] [Related]
11. Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth.
Dolinsek T; Markelc B; Sersa G; Coer A; Stimac M; Lavrencak J; Brozic A; Kranjc S; Cemazar M
PLoS One; 2013; 8(3):e58723. PubMed ID: 23593103
[TBL] [Abstract][Full Text] [Related]
12. FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway.
Feng H; Jin Z; Liang J; Zhao Q; Zhan L; Yang Z; Yan J; Kuang J; Cheng X; Qiu W
Oncogene; 2021 Oct; 40(42):6115-6129. PubMed ID: 34489549
[TBL] [Abstract][Full Text] [Related]
13. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
14. iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis.
Egorova A; Petrosyan M; Maretina M; Bazian E; Krylova I; Baranov V; Kiselev A
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631322
[TBL] [Abstract][Full Text] [Related]
15. Circ-100290 Positively Regulates Angiogenesis Induced by Conditioned Medium of Human Amnion-Derived Mesenchymal Stem Cells Through miR-449a/eNOS and miR-449a/VEGFA Axes.
Tang Z; Wu X; Hu L; Xiao Y; Tan J; Zuo S; Shen M; Yuan X
Int J Biol Sci; 2020; 16(12):2131-2144. PubMed ID: 32549760
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling.
Chen J; Wang Y; Wang S; Zhao X; Zhao L; Wang Y
J Ethnopharmacol; 2022 Jan; 283():114667. PubMed ID: 34597652
[TBL] [Abstract][Full Text] [Related]
18. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages.
Lisi L; Pia Ciotti GM; Chiavari M; Ruffini F; Lacal PM; Graziani G; Navarra P
Oncol Rep; 2020 Jun; 43(6):2083-2092. PubMed ID: 32236632
[TBL] [Abstract][Full Text] [Related]
20. Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells.
Jadhao M; Chen CL; Liu W; Deshmukh D; Liao WT; Chen JY; Urade R; Tsai EM; Hsu SK; Wang LF; Chiu CC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
